Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GE ENTERING RADIOLOGY ULTRASOUND MARKET WITH LOGIQ 700

This article was originally published in The Gray Sheet

Executive Summary

GE ENTERING RADIOLOGY ULTRASOUND MARKET WITH LOGIQ 700, the firm announced Nov. 29 at the Radiological Society of North America's annual conference in Chicago. A 510(k) for the device was submitted in February. General Electric Medical Systems will target the system to the general radiology market, including abdominal, obstetrical-gynecological, vascular and urological applications. General radiology comprises "about 40%" of the "$2 billion [worldwide] ultrasound market," John Kese, GE Medical Systems' general manager for global ultrasound, said at a press conference. The Logiq 700 will be GE Medical Systems' first attempt to compete in that segment. The firm estimates its share of the overall ultrasound market at 5-6%, with "significantly higher" market penetration in the clinical ultrasound market. GE Medical Systems currently produces ultrasound machines for the ob/gyn and urology clinical markets and for the cardiology private office market. Those systems list for roughly $30,000-$ 40,000, according to the firm, and are less versatile than hospital radiology systems, which must have the capacity to visualize major organs, vasculature, blood flow and velocities. The Logiq 700 will be priced in the $200,000 range, making it competitive to other ultrasound machines, GE says. Logiq 700's all-digital platform enables it "to deliver superior image quality and...flexibility" to accommodate future innovations, Kese stated. Kese attributed some of the system's image quality to its 128 independent digital channels. GE's Senior Vice President for Corporate Research and Development Lewis Edelheit explained that the positioning of the channels enables "multi-dimensional imaging," or "focusing in three directions" rather than the traditional two. A GE Medical Systems press release highlights other characteristics of the Logiq 700. The system will "feature parallel processing to power extremely fast color flow frame rates." In addition, the system will have "four active probe ports" that "operate in all scanning modes." The firm expects to have production quantities of the Logiq 700 three to four months following clearance. The Logiq 700 should be available during the second quarter of 1994 in Europe and Latin America. The firm is considering eventually marketing the ultrasound system for cardiology.

You may also be interested in...



Financing Quarterly Statistics, Q1 2024

During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.

Helping Organizations Deliver On KPIs And Giving Staff A Voice

ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT001569

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel